$GILD News More positive tests for hep C drug boost

New Post Public Reply Private Reply Replies (0) Message Board

Jan 31, 2014 at 4:05 PM

$GILD News

More positive tests for hep C drug boost AbbVie and Enanta shares 10:52 a.m. Today - blogs.marketwatch.com
Cash ain’t trash 1:55 p.m. Jan. 28, 2014 - The Trading Deck
Beware the dead-cat bounce 1:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 1:06 p.m. Jan. 28, 2014 - Michael Ashbaugh
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Are the prevailing technicals bullish, or bearish? 11:54 a.m. Jan. 17, 2014 - Michael Ashbaugh
U.S. stocks drop on Goldman, Citi; Nasdaq edges up 4:07 p.m. Jan. 16, 2014 - Laura Mandaro
Nu Skin sinks on China probe; Best Buy hits 6-month low 4:04 p.m. Jan. 16, 2014 - Ben Eisen
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 4:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
Mounting optimism for hepatitis C drug boosts Gilead to lead S&P 500 3:09 p.m. Jan. 16, 2014 - blogs.marketwatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
3 top trades for 2014 6:00 a.m. Dec. 30, 2013 - Jeff Reeves
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - blogs.marketwatch.com
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Saumya Vaishampayan
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:18 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com

Biotech Sector Performance January 2014 Strong, but What's Ailing Celgene? 2:12 p.m. Today - TheStreet.com
Abbvie Strong Hep C Drug Data and the Looming Battle With Gilead Sciences 10:07 a.m. Today - TheStreet.com
Gilead Sciences Inc Retains Buy Recommendation 9:00 a.m. Today - TheStreet.com
Idenix to Raise Funds, Shares up - Analyst Blog 5:20 p.m. Jan. 29, 2014 - Zacks.com
Why Caution Is Prevailing in Biotechs Into and After Earnings 11:29 a.m. Jan. 29, 2014 - 247WallSt.com
UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside 7:35 a.m. Jan. 29, 2014 - 247WallSt.com
Gilead Sciences Inc. (GILD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 29, 2014 - Zacks.com
6 Biotechnology Stocks to Buy Now 6:00 a.m. Jan. 29, 2014 - InvestorPlace.com
Don't Underestimate Amgen: Part 2A, Cardiovascular And Oncology Pipeline Products 3:01 a.m. Jan. 29, 2014 - Seeking Alpha
Gilead Sciences Inc (GILD): Today's Featured Drugs Winner 5:00 p.m. Jan. 28, 2014 - TheStreet.com
Biotechs - especially Biogen, Celgene, Gilead - have further to rise, DB says 11:58 a.m. Jan. 28, 2014 - Seeking Alpha
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised 10:22 a.m. Jan. 28, 2014 - TheStreet.com
Big cap biotech pushed at Deutsche 9:12 a.m. Jan. 28, 2014 - Seeking Alpha
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Jan. 28, 2014 - Seeking Alpha
Growth Portfolio Super Bowl: Gilead Vs. Polaris 12:09 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
CHMP Positive on Bayer's Riociguat - Analyst Blog 4:30 p.m. Jan. 27, 2014 - Zacks.com
Top 2013 Drug Approvals: Pharma Stocks 3:58 p.m. Jan. 27, 2014 - Seeking Alpha
Obamacare Boosts Health Funds 11:26 a.m. Jan. 27, 2014 - TheStreet.com

Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Today - PR Newswire - PRF
Gilead Sciences to Release Fourth Quarter and Year End 2013 Financial Results on Tuesday, February 4, 2014 5:00 p.m. Jan. 28, 2014 - BusinessWire - BZX
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America 1:15 a.m. Jan. 13, 2014 - BusinessWire - BZX
Gilead Sciences to Present at the 32nd Annual JPMorgan Healthcare Conference on Monday, January 13 5:00 p.m. Jan. 10, 2014 - BusinessWire - BZX
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire
Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Buy-Side Index Reveals State Market Variance

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Supply Maverick Simplifies Global Shipping Processes

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Sustainability Investments: $17 Trillion Wager Faces Divergence

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

NYSE Reflects on 9/11: Honoring Lives and Legacy

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Streamlined AI Video Analytics for Public Safety Unveiled

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

High-Grade Copper Spurs Optimism for PolarX in Alaska

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...